Linetic 300mg Infusion

• Treatment of Severe bacterial infections

Every medicine has some side effects that typically manage on their own as your body gets used to the medicine, but some people may experience severe side effects rarely. In that case, the patient should contact the doctor immediately.

Some common side effects of Lenvima 4mg Capsule include:

• Vomiting
• Headache
• Nausea
• Decreased blood cells (red cells, white cells, and platelets)
• Diarrhea

Contact your healthcare provider if you face any unusual or persistent side effects.   

• The recommended dose of Linetic 300mg Infusion may vary according to the type of disease, as well as age, weight, and other health factors of the patients.
• It is advised to take this injection after consulting your healthcare expert. This medicine should be given intravenously by an experienced nurse or doctor. Please do not self-administer.​​
  

• Linetic 300mg Infusion is an antibiotic with active ingredient Linezolid. It works by inhibiting bacterial protein synthesis by targeting an early stage of the process.
• It specifically binds to the 23S ribosomal RNA of the 50S ribosomal subunit, preventing the formation of the 70S initiation complex, which is necessary for translating messenger RNA (mRNA) into proteins. This mode of action stops bacterial growth and removes the infection from the body.​​
  

• Luque, S., Hope, W., Sorli, L., Muñoz-Bermudez, R., Campillo, N., Barceló-Vidal, J., ... & Grau, S. (2021). Dosage individualization of linezolid: precision dosing of linezolid to optimize efficacy and minimize toxicity. Antimicrobial Agents and Chemotherapy, 65(6), 10-1128. https://pmc.ncbi.nlm.nih.gov/articles/PMC8316043/
• Park, I. N., Hong, S. B., Oh, Y. M., Kim, M. N., Lim, C. M., Lee, S. D., ... & Shim, T. S. (2006). Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis. Journal of antimicrobial chemotherapy, 58(3), 701-704. https://pubmed.ncbi.nlm.nih.gov/16857689/
• Ament, P. W., Jamshed, N., & Horne, J. P. (2002). Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections. American family physician, 65(4), 663-671. https://pubmed.ncbi.nlm.nih.gov/11871684/
• Dietze, R., Hadad, D. J., McGee, B., Molino, L. P. D., Maciel, E. L. N., Peloquin, C. A., ... & Johnson, J. L. (2008). Early and extended early bactericidal activity of linezolid in pulmonary tuberculosis. American journal of respiratory and critical care medicine, 178(11), 1180-1185.
• Dryden, M. S. (2011). Linezolid pharmacokinetics and pharmacodynamics in clinical treatment. Journal of antimicrobial chemotherapy, 66(suppl_4), iv7-iv15.
• Perry, C. M., & Jarvis, B. (2001). Linezolid: a review of its use in the management of serious gram-positive infections. Drugs, 61(4), 525-551.